Literature DB >> 6232335

Generation and decay of the immune response to a progressive fibrosarcoma. I. Ly-1+2- suppressor T cells down-regulate the generation of Ly-1-2+ effector T cells.

R J North, I Bursuker.   

Abstract

It was shown that the progressive growth of the immunogenic meth A fibrosarcoma in its semisyngeneic host results in the generation of concomitant immunity to the growth of a tumor implant. The generation of immunity occurred between days 6 and 9 of tumor growth and was associated with the generation of sensitized T cells that were capable, on passive transfer, of causing regression of a 3-d tumor in gamma-irradiated recipients. After day 9 of tumor growth, concomitant immunity and the T cells able to passively transfer it were progressively lost, and this was associated with the generation of splenic suppressor T cells able to suppress the expression of adoptive immunity against an established tumor in T cell-deficient ( TXB ) recipients. The T cells that passively transferred concomitant immunity were shown to be of the Ly-1-2+ phenotype, in contrast to the T cells that transferred suppression, which were shown with the same reagents to be Ly-1+2-. The results are consistent with the hypothesis that the progressive growth of an immunogenic tumor results in the generation of Ly-1-2+-sensitized effector T cells that fail to reach a number sufficient to destroy the tumor because their generation is down-regulated by tumor-induced Ly-1+2- suppressor T cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6232335      PMCID: PMC2187300          DOI: 10.1084/jem.159.5.1295

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  28 in total

1.  Haplotype-specific suppressor T cells mediating linked suppression of immune responses elicited by third-party H-2 alloantigens.

Authors:  V Holán; N A Mitchison
Journal:  Eur J Immunol       Date:  1983-08       Impact factor: 5.532

2.  Suppressor T cell circuits.

Authors:  B Benacerraf; M I Greene; M S Sy; M E Dorf
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

Review 3.  Regulation of the immune response to antigens on the malignant cell surface.

Authors:  J A Drebin; L L Perry; R Carter; M I Greene
Journal:  Springer Semin Immunopathol       Date:  1982

4.  Transfer of sensitised Lyt 2+ cells triggers acute rejection of pancreatic islet allografts.

Authors:  S J Prowse; H S Warren; M Agostino; K J Lafferty
Journal:  Aust J Exp Biol Med Sci       Date:  1983-04

5.  Development of protective immunity against bacterial and viral infections in tumor-bearing mice coincident with suppression of tumor immunity.

Authors:  P F Bonventre; A D Nickol; E J Ball; J G Michael; H C Bubel
Journal:  J Reticuloendothel Soc       Date:  1982-07

6.  T cell regulation of b cell activation. Cloned Lyt-1+2-T suppressor cells inhibit the major histocompatibility complex-restricted interaction of T helper cells with B cells and/or accessory cells.

Authors:  Y Asano; R J Hodes
Journal:  J Exp Med       Date:  1983-10-01       Impact factor: 14.307

7.  Suppressor T cells activated in a primary in vitro response to non-major histocompatibility alloantigens.

Authors:  S Macphail; O Stutman
Journal:  J Exp Med       Date:  1982-11-01       Impact factor: 14.307

8.  Analysis of the mechanism of unresponsiveness produced by haptens painted on skin exposed to low dose ultraviolet radiation.

Authors:  C A Elmets; P R Bergstresser; R E Tigelaar; P J Wood; J W Streilein
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

9.  Allosuppressor- and allohelper-T cells in acute and chronic graft-vs.-host (GVH) disease. III. Different Lyt subsets of donor T cells induce different pathological syndromes.

Authors:  A G Rolink; E Gleichmann
Journal:  J Exp Med       Date:  1983-08-01       Impact factor: 14.307

10.  Expression of passively transferred immunity against an established tumor depends on generation of cytolytic T cells in recipient. Inhibition by suppressor T cells.

Authors:  C D Mills; R J North
Journal:  J Exp Med       Date:  1983-05-01       Impact factor: 14.307

View more
  81 in total

1.  Analysis of FoxP3+ T-regulatory cells and CD8+ T-cells in ovarian carcinoma: location and tumor infiltration patterns are key prognostic markers.

Authors:  Cecilia Hermans; David Anz; Jutta Engel; Thomas Kirchner; Stefan Endres; Doris Mayr
Journal:  PLoS One       Date:  2014-11-03       Impact factor: 3.240

Review 2.  Regulation of magnitude of antibody response to bacterial polysaccharide antigens by thymus-derived lymphocytes.

Authors:  P J Baker
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

3.  Gene gun-mediated skin transfection with interleukin 12 gene results in regression of established primary and metastatic murine tumors.

Authors:  A L Rakhmilevich; J Turner; M J Ford; D McCabe; W H Sun; P M Sondel; K Grota; N S Yang
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

4.  Differential sensitivity of CD8+ suppressor and cytotoxic T lymphocyte activity to bacterial monophosphoryl lipid A.

Authors:  F Esquivel; C E Taylor; P J Baker
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

5.  Implantation of a gelatin-sponge as a model for effector recruitment. Tumor growth inhibition by T-lymphocytes recovered from a site of tumor rejection.

Authors:  E T Akporiaye; M K Kudalore
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

Review 6.  CD25+ CD4+ regulatory T-cells in cancer.

Authors:  David C Linehan; Peter S Goedegebuure
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

7.  Partial CD4 depletion reduces regulatory T cells induced by multiple vaccinations and restores therapeutic efficacy.

Authors:  Michael G LaCelle; Shawn M Jensen; Bernard A Fox
Journal:  Clin Cancer Res       Date:  2009-11-10       Impact factor: 12.531

8.  The Lyt phenotype of the T cells responsible for in vivo tumor rejection in syngeneic mice.

Authors:  H Ozawa; T Iwaguchi; T Kataoka
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

9.  Potential plasticity of T regulatory cells in pancreatic carcinoma in relation to disease progression and outcome.

Authors:  Barbara Vizio; Anna Novarino; Alice Giacobino; Carmen Cristiano; Adriana Prati; Libero Ciuffreda; Giuseppe Montrucchio; Graziella Bellone
Journal:  Exp Ther Med       Date:  2012-04-18       Impact factor: 2.447

10.  Immune rejection of mouse tumors expressing mutated self.

Authors:  Fei Duan; Yun Lin; Cailian Liu; Manuel E Engelhorn; Adam D Cohen; Michael Curran; Shimon Sakaguchi; Taha Merghoub; Stephanie Terzulli; Jedd D Wolchok; Alan N Houghton
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.